Apollo Hospitals Enterprise – Detailed Fundamental Screener & Price Target
Investment View: Bullish (Long-Term Compounder)
Apollo Hospitals remains one of India’s highest-quality healthcare businesses with leadership across hospitals, diagnostics, pharmacies, and digital healthcare. The company’s expansion strategy, improving profitability, and rising demand for specialty healthcare continue to support long-term earnings growth. FY26 revenue grew 16% while net profit increased 34%, supported by higher occupancy, better case mix, and digital business improvements.
Fundamental Screener
| Parameter | Analysis | Rating |
|---|---|---|
| Business Quality | Market leader in healthcare | ⭐⭐⭐⭐⭐ |
| Revenue Growth | Strong double-digit growth | ⭐⭐⭐⭐⭐ |
| Profit Growth | Excellent | ⭐⭐⭐⭐⭐ |
| ROE | Healthy and improving | ⭐⭐⭐⭐☆ |
| ROCE | Strong capital efficiency | ⭐⭐⭐⭐☆ |
| Operating Margin | Consistently expanding | ⭐⭐⭐⭐⭐ |
| Debt | Comfortable for expansion | ⭐⭐⭐⭐☆ |
| Cash Flow | Strong operating cash generation | ⭐⭐⭐⭐⭐ |
| Promoter Quality | Excellent management | ⭐⭐⭐⭐⭐ |
| Institutional Holding | Very High | ⭐⭐⭐⭐⭐ |
| Competitive Advantage | Wide economic moat | ⭐⭐⭐⭐⭐ |
Overall Fundamental Score: 9.6/10
Business Segments
🏥 Hospitals
- Largest contributor to profits
- Premium tertiary and quaternary healthcare
- High-margin specialties:
- Cardiology
- Oncology
- Neurology
- Organ Transplants
- Orthopedics
💊 Apollo Pharmacy
- India’s largest pharmacy network
- Growing omnichannel presence
- Increasing profitability
🧪 Diagnostics
- Expanding laboratory network
- Higher operating leverage
- Cross-selling opportunities
📱 Apollo 24/7
- Digital consultations
- Medicine delivery
- Online diagnostics
- Expected to become a meaningful profit driver over time
Growth Drivers (Option Traders View)
Option Traders Must watch These Stocks to Buying Options . Movement in Healthcare Sector To Confirm The Trend .In Same Sector and Movement to watch The FNO Stocks in healthcare
- Apollo Hospitals
- Fortis Healthcare
- Max healthcare institute
1. Massive Bed Expansion
Apollo plans to significantly increase hospital capacity over the coming years, supporting long-term revenue growth. Reuters also reported the company expects mid-to-high teen revenue growth supported by specialty care demand and expansion.
2. Rising Healthcare Demand
Drivers include:
- Aging population
- Lifestyle diseases
- Higher insurance penetration
- Medical tourism
- Increasing income levels
These create a long runway for premium healthcare providers.
3. Premium Specialties
High-value procedures continue to grow faster than general healthcare:
- Oncology
- Cardiac Sciences
- Neurosciences
- Organ Transplants
These specialties improve margins and average revenue per patient.
4. Digital Healthcare
Apollo 24/7 is improving profitability through:
- Online consultations
- Digital pharmacy
- Health subscriptions
- Better patient retention
5. Strong Brand
Apollo remains one of India’s most trusted hospital brands, giving it pricing power and high patient loyalty.
Strengths
✅ Market leader
✅ Premium pricing power
✅ Strong cash generation
✅ Multiple revenue streams
✅ Excellent management
✅ Long growth runway
✅ High institutional confidence
Risks
- High valuation compared with the broader market
- Execution risk in large hospital expansions
- Competition from premium hospital chains
- Regulatory changes affecting healthcare pricing
- Initial pressure on margins from newly commissioned hospitals until occupancy improves.
Technical Outlook
Trend: Strong Bullish
- Higher highs and higher lows
- Strong institutional buying
- Long-term moving averages remain supportive
- Suitable for accumulation on corrections rather than chasing sharp rallies
Earnings Outlook
Analysts expect growth to be driven by:
- Higher occupancy
- Improved realization per bed
- Margin expansion
- Better contribution from digital and pharmacy businesses
- Continued hospital capacity additions.
Price Target
| Time Period | Target |
|---|---|
| 12 Months | ₹9,000–9,300 |
| 2 Years | ₹10,500–11,500 |
| 3–5 Years | ₹14,000–16,500 |
| 2030 (Bull Case) | ₹18,000–22,000 |
These are scenario-based estimates derived from expected earnings growth, expansion plans, and valuation assumptions—not guaranteed future prices.
Suitable For
- ✅ Long-term investors
- ✅ SIP investors
- ✅ Portfolio core holding
- ✅ Healthcare sector allocation
- ✅ Moderate-risk investors







5